Veterinary Medicines

Insol Dermatophyton Zawiesina do wstrzykiwań

Authorised
  • Trichophyton verrucosum, strain 410, Inactivated
  • Trichophyton sarkisovii, strain 551, Inactivated
  • Trichophyton equinum, strain 381, Inactivated
  • Trichophyton mentagrophytes, strain 1032, Inactivated
  • Microsporum canis, strain 1393, Inactivated
  • Microsporum distortum, strain 120, Inactivated
  • Microsporum obesum, strain 1311, Inactivated
  • Microsporum gypseum, strain 59, Inactivated
Download as PDF

Product identification

Medicine name:
Insol Dermatophyton Zawiesina do wstrzykiwań
Active substance:
  • Trichophyton verrucosum, strain 410, Inactivated
  • Trichophyton sarkisovii, strain 551, Inactivated
  • Trichophyton equinum, strain 381, Inactivated
  • Trichophyton mentagrophytes, strain 1032, Inactivated
  • Microsporum canis, strain 1393, Inactivated
  • Microsporum distortum, strain 120, Inactivated
  • Microsporum obesum, strain 1311, Inactivated
  • Microsporum gypseum, strain 59, Inactivated
Target species:
  • Cat
  • Horse
  • Dog
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Trichophyton verrucosum, strain 410, Inactivated
  • Trichophyton sarkisovii, strain 551, Inactivated
  • Trichophyton equinum, strain 381, Inactivated
  • Trichophyton mentagrophytes, strain 1032, Inactivated
  • Microsporum canis, strain 1393, Inactivated
  • Microsporum distortum, strain 120, Inactivated
  • Microsporum obesum, strain 1311, Inactivated
  • Microsporum gypseum, strain 59, Inactivated
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cat
      • All relevant tissues
        no withdrawal period
    • Horse
    • Dog
      • All relevant tissues
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI05AQ02
  • QI06AQ01
  • QI07AQ01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Poland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Wirtschaftsgenossenschaft Deutscher Tierarzte eG
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 1405
Date of authorisation status change:

Documents

Labelling

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 27/04/2022
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 27/04/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 6/02/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."